Skip to main content
EPKINLY 4 mg/.8mL injection, solution by Genmab US, Inc.
EPKINLY, 4 mg/.8mL, injection, solution Drug class: Bispecific CD20-directed CD3 T Cell Engager. Available on prescription only. Listed by Genmab US, Inc..
Prescription only

EPKINLY

epcoritamab-bysp

Listed by Genmab US, Inc.

Strength
4 mg/.8mL
Form
Injection, Solution
Route
Subcutaneous
Class
Bispecific CD20-directed CD3 T Cell Engager

What it contains

  • Epcoritamab 4 mg/.8mL

FDA record

Dosage form Injection, Solution
Route Subcutaneous
Drug class Bispecific CD20-directed CD3 T Cell Engager
Approval route BLA — biologic licence
NDC code 82705-002
FDA application BLA761324
RxNorm concept 2637399
Package sizes listed 1
Marketed since May 2023

Other products containing Epcoritamab

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

EPKINLY

epcoritamab-bysp

Strength
48 mg/.8mL
Form
Injection, Solution
Class
Bispecific CD20-directed CD3 T Cell Eng…
Rx only

Genmab US, Inc.

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.